Application of Proteomics in the Search for Novel Proteins Associated with the Anti-cancer Effect of the Synthetic Cyclin-dependent Kinases Inhibitor, Bohemine

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Technology in Cancer Research and Treatment

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1177/153303460200100405PMID 12625783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.

  2002cited by this paper
• Advances in Rho-dependent actin regulation and oncogenic transformation.

  2002cited by this paper
• Cluster analysis of an extensive human breast cancer cell line protein expression map database

  2002cited by this paper
• Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer.

  2001cited by this paper
• Poor Prognosis in Nasopharyngeal Cancer Patients with Low Glucose‐6‐phosphate‐dehydrogenase Activity

  2001cited by this paper
• Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells.

  2001cited by this paper
• Cell-cycle dysregulation and the molecular mechanisms of prostate cancer.

  2000cited by this paper
• Modulation of paclitaxel resistance by annexin IV in human cancer cell lines

  2000cited by this paper
• The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma

  2000cited by this paper
• 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.

  2000cited by this paper
• Expression of Tumor Suppressor Gene p16INK4 Products in Primary Gastric Cancer

  2000cited by this paper
• Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues

  2000cited by this paper
• Inhibition of CDKs as a Therapeutic Modality

  2000cited by this paper
• Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma.

  2000cited by this paper
• γδ T cells lyse autologous and allogenic oesophageal tumours: involvement of heat-shock proteins in the tumour cell lysis

  2000cited by this paper
• Heat shock protein expression independently predicts clinical outcome in prostate cancer.

  2000cited by this paper
• Upregulation of lipocortin 1 inhibits tumour necrosis factor‐induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance

  2000cited by this paper
• Identification and Characterization of Human SLP-2, a Novel Homologue of Stomatin (Band 7.2b) Present in Erythrocytes and Other Tissues*

  2000cited by this paper
• Human CLP36, a PDZ-domain and LIM-domain protein, binds to alpha-actinin-1 and associates with actin filaments and stress fibers in activated platelets and endothelial cells.

  2000cited by this paper
• Different expression of CD44, ICAM-1, and HSP60 on primary tumor and metastases of a human pancreatic carcinoma growing in scid mice.

  2000cited by this paper
• The Pezcoller lecture: cancer cell cycles revisited.

  2000cited by this paper
• Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.

  2000cited by this paper
• Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine‐derived synthetic cyclin‐dependent kinase inhibitor, bohemine

  2000cited by this paper
• Cloning and Functional Analysis of cDNAs with Open Reading Frames for 300 Previously Undefined Genes Expressed in CD 34 + Hematopoietic Stem / Progenitor Cells

  2000cited by this paper
• Synthetic Cyclin Dependent Kinase Inhibitors

  1999cited by this paper
• High prevalence of p16 genetic alterations in head and neck tumours

  1999cited by this paper
• The p 16-Cyclin D 1 / CDK 4-pRb Pathway and Clinical Outcome in Epithelial Ovarian Cancer 1

  1999cited by this paper
• Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma.

  1999cited by this paper
• Search for novel proteins involved in the development of chemoresistance in colorectal cancer and fibrosarcoma cells in vitro using two‐dimensional electrophoresis, mass spectrometry and microsequencing

  1999cited by this paper
• Quantifying protein in 2-D PAGE solubilization buffers.

  1999cited by this paper
• Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs.

  1999cited by this paper
• The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer.

  1999cited by this paper
• The p16INK4a/CDKN2A tumor suppressor and its relatives.

  1998cited by this paper
• Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells.

  1998cited by this paper
• Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.

  1998cited by this paper
• Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.

  1997cited by this paper
• Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine.

  1997cited by this paper
• Protein expression profiles in human breast ductal carcinoma and histologically normal tissue

  1997cited by this paper
• Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

  1997cited by this paper
• The retinoblastoma protein pathway and the restriction point.

  1996cited by this paper
• Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Unrestricted cell cycling and cancer

  1995cited by this paper
• Inhibition of cyclin-dependent kinases by purine analogues.

  1994cited by this paper
• Guidelines for implementation of clinical DNA cytometry

  1993cited by this paper
• A nonlinear wide‐range immobilized pH gradient for two‐dimensional electrophoresis and its definition in a relevant pH scale

  1993cited by this paper
• Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology.

  1993cited by this paper
• Human liver protein map: A reference database established by microsequencing and gel comparison

  1992cited by this paper
• Identification of mouse brain proteins after two‐dimensional electrophoresis and electroblotting by microsequence analysis and amino acid composition analysis

  1988cited by this paper
• Mortality in relation to histologic type in Hodgkin's disease.

  1956cited by this paper

• Oncoproteomics: Opportunities, Challenges & Advanced Technologies

  2019cites this paper
• Challenges in cancer research and multifaceted approaches for cancer biomarker quest

  2009cites this paper
• Stress response of mammalian cells incubated with landfill leachate

  2008cites this paper
• Cyclin‐Dependent Kinase Inhibitors and Cancer: Usefulness of Proteomic Approaches in Assessment of the Molecular Mechanisms and Efficacy of Novel Therapeutics

  2008cites this paper
• Mass spectrometrical verification of stomatin‐like protein 2 (SLP‐2) primary structure

  2006cites this paper
• The Protein Profile of the Human Immature T-cell Line CCRF-CEM.

  2005cites this paper
• Metabolic dynamics in cells viewed as multilayered, distributed, mass‐energy‐information networks

  2005cites this paper
• Asthma, the ugly duckling of lung disease proteomics?

  2005cites this paper
• Protein Fingerprints of Anti-cancer Effects of Cyclin-dependent Kinase Inhibition: Identification of Candidate Biomarkers Using 2-D Liquid Phase Separation Coupled to Mass Spectrometry

  2005cites this paper
• Novel strategies in cancer therapeutics: targeting enzymes involved in cell cycle regulation and cellular proliferation.

  2004cites this paper
• Proteomics in biomarker discovery and drug development

  2003cites this paper
• Oncoproteomics: State-of-the-Art

  2002cites this paper